Evidence map›Paper›PMID 11040958›Full record

ReviewAdvances in clinical chemistry2000

Cystatin C--properties and use as diagnostic marker.

A O Grubb

Abstract readReview
In one paragraph

Review in Advances in clinical chemistry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Observational
  13. Article
  14. Cystatin C and Kidney Function Recovery in Patients Requiring Continuous KRT for Acute Kidney Injury.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Early biomarkers for kidney injury in heat-related illness patients: a prospective observational study at Japanese Self-Defense Force Fuji Hospital.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Observational
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

A O GrubbDepartment of Clinical Chemistry, University Hospital, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersAmino Acid SequenceAnimalsBase SequenceCerebral HemorrhageCystatin CCystatinsCysteine Proteinase InhibitorsHumansKidneyMolecular Sequence DataPhylogenyReference ValuesBiomarkersCST3 protein, humanCystatin CCystatinsCysteine Proteinase Inhibitors

Identifiers

PMID11040958
PMCPMC7130541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.